Live Breaking News & Updates on Capital District Physicians Health Plan

Stay updated with breaking news from Capital district physicians health plan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Transcripts For CSPAN3 Forum On Pharmaceutical Development And Drug Costs 20151125

Hepatitis c, diabetes and oncology are the primary drivers of the spending growth. Prescription growth is 1. 2 for the year. That is a substantial reduction from last year. The primary effect is the rescheduling of hydrocodone to more restrictive schedule which cut that market by 30 . And also you have more chronic care prescriptions are 90day prescriptions. 75 is on specialists. You cant look at that market here or everywhere around the World Without talking specialty. And next year we expect crestor to go off. So these are whats driving spending growth. You can see hepatitis at the top followed by diabetes, oncology, autoimmune, multiple sclerosis, hiv, respiratory, nervous system, and so forth. Almost all of the big five are in the specialty area. And if you look closely at the slide, and i assume youll get copies of this later, what the significant impacts are in each of these things and we break it down by new brands, whats go ....

New York , United States , New Jersey , Michael Dukakis , Doris Peter , Peter Bach , Steve Miller , Peter Newman , Sloan Kettering , Ronald Reagan , World Without , College Little , Side Side , Big Year , Top Ten , 20 30 , Lower Cost , Health Care , Health Care Spending , Specialty Products , Medicare Medicaid , Rare Diseases , Disease State , Rare Disease , Six Things , Big Problem ,

Transcripts For CSPAN3 Politics And Public Policy Today 20151130

Arrangement, and are you guaranteeing what is the price of the drug when are you saying you are only going to get paid x if you reach a cure level or certain level of adherence. Theres some interference there, and its used as an excuse for those types of arrangement or getting out of those arrangements by pharmaceutical companies. The other is the fda approves the drug if it works. And they dont necessarily approve it saying whether it works better than things that have previously been approved or whether it doesnt work better than thing previously approved. And that can create some friction when it comes to dealing with providers who seem to want to gravitate toward the newest and the latest, even if it really doesnt turn out to work any better than some of the alternatives that have come down the pike before. So whats the solution there . More as we heard on the earlier panel, more effectiveness, information and data . I think the comparative effectiveness would really help. Then you ....

New York , United States , Ken Frasier , Peter Bach , Dan Durham , Bernard Tyson , Jenna Woodcock , Alan Spielman , Sam Nusbaum , Steve Miller , Elizabeth Wright , Randall S Olsen , Kaiser Permanente , Steve Pearson , Price Drug , Better Things , Healthy Behaviors , Look Health , Health Plans , Better Care , Investment Decisions , Many People , Public Health , Public Health Issues , Health Issues , Disease Management Program ,

Editorial: Fictional mental health care

Editorial: Fictional mental health care
timesunion.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from timesunion.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Letitia Jame , Office Of Mental Health , Department Of Health , Department Of Financial Services , Capital District Physicians Health Plan , New York Attorney General Letitia Jame , Mental Health , Financial Services , Psychology Interjurisdictional Compact ,